Findings from a new study conducted by novel therapeutics cancer firm Sunstone Therapies and the University of Vermont’s Conversation Lab show the feasibility of trained human coders to identify observable markers of therapeutic connection during psilocybin administration within Psychedelic-Assisted Therapy (PAT.)